PER percheron therapeutics limited

Ann: Quarterly Activities Report and Appendix 4C, page-2

  1. 1,123 Posts.
    lightbulb Created with Sketch. 547
    This was interesting re the much discussed Ionis relationship:

    Percheron remains obligated to use commercially reasonable efforts to bring products into commercial use as quickly as is reasonably possible. Percheron also retains access to relevant Ionis know-how and an obligation to pay certain royalties to Ionis based on commercialization proceeds received by Percheron. The revised agreement, now titled the 'Royalty Agreement', otherwise serves to retire certain research and development-focused provisions of the original which are no longer applicable.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.0¢
Change
0.000(0.00%)
Mkt cap ! $10.87M
Open High Low Value Volume
1.0¢ 1.0¢ 1.0¢ $71.80K 7.180M

Buyers (Bids)

No. Vol. Price($)
1 4649246 1.0¢
 

Sellers (Offers)

Price($) Vol. No.
1.1¢ 2600000 2
View Market Depth
Last trade - 15.21pm 13/06/2025 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.